Potential therapeutic system for Alzheimer’s disease by removal of blood Aβ; Efficient Aβ removal system by enhancing adsorption on hollow fibers with hemodiafiltration. (Alzheimer’s Association International Conference AAIC 2016 2016)
Evidence supporting a therapeutic strategy for Alzheimer’s disease by removal of blood amyloid; Patients that have undergone hemodialysis exhibit lower Amyloid deposition in the brain. (Alzheimer’s Association International Conference AAIC 2016 2016)
As a model of extracorporeal blood A-beta removal system for Alzheimer’s Disease therapy: Prospective study of hemodialysis. (The 12th International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD 2015) 2015)
Therapeutic Effect of Nonwoven Biodegradable Filters with Mesenchymal Stem Cells on a Rat Model of Chronic Renal Failure. (41st Annual ESAO Congress (European Society for Artificial Organs ESAO2014) 2014)
Extracorporeal Aβ Removal System for Alzheimer’s Disease Therapy: Most Effective Materials. (41st Annual ESAO Congress (European Society for Artificial Organs, ESAO2014) 2014)
Therapeutic effect of nonwoven polyester filters with/without peripheral-blood cells on a rat model of chronic renal failure (5th Congress of the International Federation for Artificial Organs 2013)
Toward the novel method of treatment for Alzheimer's disease; The optimal conditions of Aβ removal by dialyzers (5th Congress of the International Federation for Artificial Organs 2013)
Removal of blood Aβ might reduce brain Aβ deposition based on the study of hemodialysis patients:Extracorporeal Aβ Removal System (EARS) for Alzheimer’s Disease therapy (Alzheimer’s Association International Conference AAIC 2013 2013)